SciELO - Scientific Electronic Library Online

 
vol.35 issue2Is COVID-19 that different in hemodialysis patients?: A single-center experienceImmature hemodialysis arteriovenous fistulas: What should we aim for? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Portuguese Journal of Nephrology & Hypertension

Print version ISSN 0872-0169

Abstract

DONATO, Beatriz; TEIXEIRA, Catarina; VELHO, Sónia  and  ALMEIDA, Edgar. Sarcopenia in chronic kidney disease - A brief review. Port J Nephrol Hypert [online]. 2021, vol.35, n.2, pp.99-105.  Epub June 29, 2021. ISSN 0872-0169.  https://doi.org/10.32932/pjnh.2021.07.129.

Sarcopenia is a progressive age‑related loss of muscle mass associated with a decline in muscle function and physical performance. Patients with chronic kidney disease experience substantial loss of muscle mass, weakness, and poor physical performance. Indeed, with the progression of chronic kidney disease, skeletal muscle dysfunction contributes to mobility limitation, loss of functional independence, and vulnerability to disease complications.

There is a lack of robust data on the negative effect of the impact of kidney disease on skeletal muscle dysfunction, as well as on screening and treatment strategies that can be used in clinical practice to prevent functional decline and disability. Therefore, sarcopenia may be na underestimated condition with major implications for people with chronic kidney disease, even before the start of dialysis, which makes research into this topic necessary.

The purpose of this review is to expand on some fundamental topics of sarcopenia, with an emphasis on the setting of chronic kidney disease patients.

Keywords : Aging; Chronic Kidney Disease; Sarcopenia..

        · text in English     · English ( pdf )